Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular senescence pathway is a biological process leading to a stable cell cycle arrest, triggered by various stressors. It involves the p53/p21 and p16/Rb pathways, resulting in characteristic phenotypic changes and the secretion of the Senescence-Associated Secretory Phenotype (SASP). While initially beneficial for tumor suppression and tissue repair, chronic activation contributes to aging-related pathologies.
Senolytics selectively eliminate senescent cells by targeting their survival pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular Senescence Pathway.